| scholarly article | Q13442814 |
| P2093 | author name string | Wenlei Liu | |
| Sridhar Duvvuri | |||
| Zhiyong Xie | |||
| Estibaliz Arce | |||
| Rita Balice-Gordon | |||
| Rouba Kozak | |||
| Brian T Harel | |||
| Christopher Chatham | |||
| David L Gray | |||
| Garry D Honey | |||
| Gabriel H Braley | |||
| Lovingly Park | |||
| Melissa Graham Naylor | |||
| Nicholas DeMartinis | |||
| P2860 | cites work | Putting brain training to the test | Q24594935 |
| Functional magnetic resonance imaging in schizophrenia | Q24635437 | ||
| Assessing the heritability of attentional networks | Q24805110 | ||
| “Mini-mental state” | Q25938989 | ||
| Prefrontal cortex and basal ganglia control access to working memory | Q28260326 | ||
| Development and validation of brief measures of positive and negative affect: The PANAS scales | Q29614730 | ||
| Video game training enhances cognitive control in older adults | Q30575914 | ||
| Adrogolide HCl (ABT-431; DAS-431), a prodrug of the dopamine D1 receptor agonist, A-86929: preclinical pharmacology and clinical data | Q30662736 | ||
| Worth the 'EEfRT'? The effort expenditure for rewards task as an objective measure of motivation and anhedonia | Q33492765 | ||
| Striatal dopamine predicts outcome-specific reversal learning and its sensitivity to dopaminergic drug administration | Q34133214 | ||
| Synopsis of some recent tactical application of bioisosteres in drug design | Q34171394 | ||
| Targeting the dopamine D1 receptor in schizophrenia: insights for cognitive dysfunction | Q34317550 | ||
| Fractionating human intelligence. | Q34319050 | ||
| Dynamic dopamine modulation in the basal ganglia: a neurocomputational account of cognitive deficits in medicated and nonmedicated Parkinsonism | Q34392452 | ||
| Dose-dependent effects of the dopamine D1 receptor agonists A77636 or SKF81297 on spatial working memory in aged monkeys. | Q34442877 | ||
| Single dose of a dopamine agonist impairs reinforcement learning in humans: evidence from event-related potentials and computational modeling of striatal-cortical function | Q34554544 | ||
| Toward the future of psychiatric diagnosis: the seven pillars of RDoC | Q34721927 | ||
| Dopamine-mediated learning and switching in cortico-striatal circuit explain behavioral changes in reinforcement learning | Q34726418 | ||
| Catechol O -methyltransferase val 158 -met genotype and individual variation in the brain response to amphetamine | Q35023131 | ||
| Schizophrenia and the D1 receptor: focus on negative symptoms | Q35264032 | ||
| A common discrete resource for visual working memory and visual search | Q35670825 | ||
| Individual differences in recovery time from attentional capture | Q35827853 | ||
| The neostriatal mosaic: multiple levels of compartmental organization in the basal ganglia | Q36064948 | ||
| Neural measures reveal individual differences in controlling access to working memory. | Q51987005 | ||
| Neural activity predicts individual differences in visual working memory capacity. | Q52001274 | ||
| Dopamine D1 receptor mechanisms in the cognitive performance of young adult and aged monkeys. | Q52056465 | ||
| Effects of dextroamphetamine on cognitive performance and cortical activation. | Q52166001 | ||
| PF-06649751 efficacy and safety in early Parkinson's disease: a randomized, placebo-controlled trial | Q90576886 | ||
| A novel approach to evaluate the pharmacodynamics of a selective dopamine D1/D5 receptor partial agonist (PF-06412562) in patients with stable schizophrenia | Q91542201 | ||
| Evaluation of D1/D5 Partial Agonist PF-06412562 in Parkinson's Disease following Oral Administration | Q93214330 | ||
| Functional significance of central D1 receptors in cognition: beyond working memory | Q36079298 | ||
| Selective reinforcement learning deficits in schizophrenia support predictions from computational models of striatal-cortical dysfunction | Q36155336 | ||
| Using human brain imaging studies as a guide toward animal models of schizophrenia. | Q36332602 | ||
| Biologically based computational models of high-level cognition | Q36615578 | ||
| Are prescription stimulants "smart pills"? The epidemiology and cognitive neuroscience of prescription stimulant use by normal healthy individuals | Q36666847 | ||
| Recent advances in the development of novel pharmacological agents for the treatment of cognitive impairments in schizophrenia | Q36886717 | ||
| Dopamine modulates risk-taking as a function of baseline sensation-seeking trait | Q37076311 | ||
| The relationship between working memory capacity and broad measures of cognitive ability in healthy adults and people with schizophrenia | Q37102394 | ||
| Working memory capacity predicts effects of methylphenidate on reversal learning | Q37103313 | ||
| Complex working memory span tasks and higher-order cognition: a latent-variable analysis of the relationship between processing and storage | Q37523534 | ||
| Systematic review of the Hawthorne effect: new concepts are needed to study research participation effects | Q37671448 | ||
| Magnetic resonance imaging in studying schizophrenia, negative symptoms, and the glutamate system | Q38207021 | ||
| Distinct dopaminergic control of the direct and indirect pathways in reward-based and avoidance learning behaviors | Q38207415 | ||
| Neurocognitive enhancement or impairment? A systematic meta-analysis of prescription stimulant effects on processing speed, decision-making, planning, and cognitive perseveration | Q38907661 | ||
| An investigation into aripiprazole's partial D₂ agonist effects within the dorsolateral prefrontal cortex during working memory in healthy volunteers | Q39837691 | ||
| Dopamine Activation Preserves Visual Motion Perception Despite Noise Interference of Human V5/MT. | Q41027308 | ||
| Computing reward-prediction error: an integrated account of cortical timing and basal-ganglia pathways for appetitive and aversive learning | Q41169632 | ||
| Trial-unique, delayed nonmatching-to-location (TUNL): a novel, highly hippocampus-dependent automated touchscreen test of location memory and pattern separation. | Q41685607 | ||
| Dopamine-mediated stabilization of delay-period activity in a network model of prefrontal cortex | Q41724350 | ||
| The Mind Bending Quest for Cognitive Enhancers | Q42128743 | ||
| Toward New Approaches to Psychotic Disorders: The NIMH Research Domain Criteria Project | Q42399695 | ||
| Conjugation of catechols by recombinant human sulfotransferases, UDP-glucuronosyltransferases, and soluble catechol O-methyltransferase: structure-conjugation relationships and predictive models. | Q44550597 | ||
| Enhancement of working memory in aged monkeys by a sensitizing regimen of dopamine D1 receptor stimulation. | Q44762687 | ||
| By carrot or by stick: cognitive reinforcement learning in parkinsonism | Q45140702 | ||
| A functional magnetic resonance imaging study of the effects of pergolide, a dopamine receptor agonist, on component processes of working memory | Q46147775 | ||
| Differential contributions of prefrontal and hippocampal dopamine D(1) and D(2) receptors in human cognitive functions | Q46250301 | ||
| A proof-of-concept, randomized controlled trial of DAR-0100A, a dopamine-1 receptor agonist, for cognitive enhancement in schizophrenia | Q46330442 | ||
| Working memory capacity predicts dopamine synthesis capacity in the human striatum. | Q46782238 | ||
| The effect of cognitive training on evoked potentials in schizophrenia | Q47551677 | ||
| Opponent actor learning (OpAL): modeling interactive effects of striatal dopamine on reinforcement learning and choice incentive | Q47743100 | ||
| D1- versus D2-receptor modulation of visuospatial working memory in humans. | Q48493267 | ||
| A mechanistic account of striatal dopamine function in human cognition: psychopharmacological studies with cabergoline and haloperidol | Q48499940 | ||
| Effects of bromocriptine on human subjects depend on working memory capacity | Q48565561 | ||
| Possible role of dopamine D1 receptors in schizophrenia | Q48667793 | ||
| Decreased prefrontal dopamine D1 receptors in schizophrenia revealed by PET. | Q48800661 | ||
| Impaired β-arrestin recruitment and reduced desensitization by non-catechol agonists of the D1 dopamine receptor | Q49234399 | ||
| P275 | copyright license | Creative Commons Attribution-NonCommercial 4.0 International | Q34179348 |
| P6216 | copyright status | copyrighted | Q50423863 |
| P577 | publication date | 2020-02-14 | |
| P1433 | published in | The International Journal of Neuropsychopharmacology | Q7742309 |
| P1476 | title | A Neurofunctional Domains Approach to Evaluate D1/D5 Dopamine Receptor Partial Agonism on Cognition and Motivation in Healthy Volunteers With Low Working Memory Capacity |
Search more.